Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica
Recurrence/progression-free survival and overall survival among... | Download Scientific Diagram
Progression-free survival and overall survival curves for all patients... | Download Scientific Diagram
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full
Cancers | Free Full-Text | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials | Journal for ImmunoTherapy of Cancer
Kaplan-Meier survival curves of progression-free survival and overall... | Download Scientific Diagram
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
Progression free survival and overall survival in patients treated with... | Download Scientific Diagram
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials - ScienceDirect
The Arts, Sciences and Medicine: Progression Free Survival (PFS)
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
Extrapolation from Progression Free Survival to Overall Survival in Oncology | PPT
